Mason Street Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-85,976
Closed -$7.84M 420
2020
Q4
$7.84M Sell
85,976
-1,349
-2% -$123K 0.13% 140
2020
Q3
$6.97M Sell
87,325
-1,141
-1% -$91.1K 0.14% 133
2020
Q2
$6.11M Sell
88,466
-808
-0.9% -$55.8K 0.12% 149
2020
Q1
$5.61M Hold
89,274
0.13% 146
2019
Q4
$6.94M Buy
89,274
+387
+0.4% +$30.1K 0.13% 135
2019
Q3
$6.52M Sell
88,887
-321
-0.4% -$23.5K 0.13% 138
2019
Q2
$5.49M Buy
89,208
+285
+0.3% +$17.5K 0.11% 167
2019
Q1
$5.67M Buy
88,923
+504
+0.6% +$32.1K 0.11% 165
2018
Q4
$4.51M Buy
88,419
+114
+0.1% +$5.82K 0.11% 169
2018
Q3
$5.13M Sell
88,305
-414
-0.5% -$24K 0.11% 177
2018
Q2
$4.31M Buy
88,719
+951
+1% +$46.1K 0.09% 208
2018
Q1
$4.08M Sell
87,768
-663
-0.7% -$30.8K 0.09% 218
2017
Q4
$3.32M Buy
88,431
+492
+0.6% +$18.5K 0.07% 297
2017
Q3
$3.2M Buy
87,939
+585
+0.7% +$21.3K 0.08% 288
2017
Q2
$3.44M Sell
87,354
-741
-0.8% -$29.2K 0.09% 256
2017
Q1
$2.76M Buy
88,095
+348
+0.4% +$10.9K 0.07% 330
2016
Q4
$2.74M Buy
87,747
+1,353
+2% +$42.3K 0.07% 318
2016
Q3
$3.47M Buy
86,394
+825
+1% +$33.2K 0.1% 214
2016
Q2
$2.85M Sell
85,569
-186
-0.2% -$6.18K 0.08% 270
2016
Q1
$2.52M Buy
85,755
+1,215
+1% +$35.7K 0.08% 309
2015
Q4
$2.23M Buy
84,540
+1,074
+1% +$28.3K 0.07% 340
2015
Q3
$1.98M Buy
83,466
+366
+0.4% +$8.67K 0.07% 365
2015
Q2
$1.97M Sell
83,100
-228
-0.3% -$5.41K 0.06% 393
2015
Q1
$1.98M Sell
83,328
-89,160
-52% -$2.12M 0.06% 408
2014
Q4
$3.66M Sell
172,488
-3,252
-2% -$69K 0.03% 687
2014
Q3
$2.99M Sell
175,740
-18
-0% -$306 0.02% 753
2014
Q2
$2.52M Sell
175,758
-8,628
-5% -$123K 0.02% 847
2014
Q1
$2.28M Sell
184,386
-5,160
-3% -$63.8K 0.02% 885
2013
Q4
$2.08M Sell
189,546
-19,980
-10% -$219K 0.02% 926
2013
Q3
$2.43M Sell
209,526
-68,994
-25% -$801K 0.03% 615
2013
Q2
$3.12M Buy
+278,520
New +$3.12M 0.03% 532